GlobalData on MSN20d
How Dexcom and ÅŒURA are unifying two distinct market sectors
Dexcom bet on the high financial ceiling that exists by integrating its glucose monitoring capabilities into the ring, culminating in a $75m investment in Ō ...
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
The Motley Fool4d
Should You Buy DexCom Stock Before Feb. 13?
The medical device company has seen its growth rate take a hit in recent quarters. DexCom blames its restructuring, but rising demand for GLP-1 drugs could be an issue. The stock's valuation has ...
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...
American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
American Diversified Holdings Corporation (OTC Pink: ADHC) pleased to provide the shareholder community an update on the ...
Yahoo Finance20d
How Dexcom and ÅŒURA are unifying two distinct market sectors
including Dexcom’s glucose biosensors and apps, as well as the Oura Ring and accompanying app. The first app integration is expected to roll out in the first half of 2025. Importantly ...